The Advisory Board Company (NASDAQ:ABCO) Stake Held by Metropolitan Life Insurance Co. NY

Metropolitan Life Insurance Co. NY held its position in The Advisory Board Company (NASDAQ:ABCO) during the first quarter, according to its most recent filing with the SEC. The firm owned 28,895 shares of the business services provider’s stock at the end of the first quarter. Metropolitan Life Insurance Co. NY owned about 0.07% of The Advisory Board worth $1,352,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of ABCO. Victory Capital Management Inc. purchased a new position in shares of The Advisory Board during the first quarter worth approximately $109,000. Howard Hughes Medical Institute bought a new stake in shares of The Advisory Board during the first quarter worth $158,000. Asset Management One Co. Ltd. bought a new stake in shares of The Advisory Board during the first quarter worth $159,000. Ameritas Investment Partners Inc. bought a new stake in shares of The Advisory Board during the first quarter worth $166,000. Finally, Highbridge Capital Management LLC bought a new stake in shares of The Advisory Board during the fourth quarter worth $217,000.

Shares of The Advisory Board Company (NASDAQ ABCO) traded up 1.08% during mid-day trading on Friday, hitting $51.60. 392,722 shares of the stock traded hands. The stock has a market cap of $2.10 billion, a PE ratio of 19.60 and a beta of 1.33. The Advisory Board Company has a one year low of $24.85 and a one year high of $59.50. The stock has a 50-day moving average of $54.58 and a 200 day moving average of $49.96.

The Advisory Board (NASDAQ:ABCO) last released its quarterly earnings results on Tuesday, August 8th. The business services provider reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by $0.08. The Advisory Board had a return on equity of 12.69% and a net margin of 13.65%. The company had revenue of $200.30 million for the quarter, compared to analyst estimates of $196.16 million. During the same period in the previous year, the business posted $0.46 EPS. The firm’s quarterly revenue was up 1.0% compared to the same quarter last year. Equities analysts predict that The Advisory Board Company will post $1.89 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “The Advisory Board Company (NASDAQ:ABCO) Stake Held by Metropolitan Life Insurance Co. NY” was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.com-unik.info/2017/08/19/the-advisory-board-company-nasdaqabco-position-maintained-by-metropolitan-life-insurance-co-ny-updated-updated-updated.html.

A number of brokerages have weighed in on ABCO. Robert W. Baird reiterated an “outperform” rating and set a $65.00 price target (up from $57.00) on shares of The Advisory Board in a research report on Sunday, July 9th. Zacks Investment Research cut shares of The Advisory Board from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 25th. BidaskClub cut shares of The Advisory Board from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $56.00 price target (up from $53.00) on shares of The Advisory Board in a research report on Thursday, August 10th. Finally, Credit Suisse Group lifted their price objective on shares of The Advisory Board from $54.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, May 5th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $51.42.

About The Advisory Board

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Institutional Ownership by Quarter for The Advisory Board (NASDAQ:ABCO)

What are top analysts saying about The Advisory Board Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for The Advisory Board Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit